UNITY Biotechnology, Inc. to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference September 5, 2018 at 4:05 PM EDT PDF Version SAN FRANCISCO, Sept. 05, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that Keith Leonard, chairman and chief executive officer, will participate in a fireside chat at the Morgan Stanley 16th Annual Global Healthcare Conference in New York, NY on Friday, September 14, 2018, at 8:45 a.m. ET. A live audio webcast will be available through the Investors & Media section of UNITY’s website. An archived replay will be available for 90 days following the event. About UNITY UNITY Biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter. Investors Endurance AdvisorsElizabeth Broderebroder@enduranceadvisors.com Media Austine GraffUnity Biotechnology 707-593-6151 Austine.Graff@unitybiotechnology.com Source: Unity Biotechnology, Inc.